Open AccessA case of combined hamartoma of the retina and retinal pigment epithelium with response to intravitreal ganciclovir injection
Author(s) -
Lísia Barros Ferreira,
Alexandra L. Farrall,
João M. Furtado,
Justine R. Smith
Publication year - 2022
Publication title -
arquivos brasileiros de oftalmologia
Language(s) - English
Resource type - Journals
eISSN - 1678-2925
pISSN - 0004-2749
DOI - 10.5935/0004-2749.20220094
Subject(s) - retinal pigment epithelium , retina , hamartoma , ophthalmology , ganciclovir , medicine , retinal , biology , pathology , neuroscience , virology , virus , human cytomegalovirus
Uveitis is a broad term that refers to a large group of eye disorders categorized by intraocular inflammation, a leading cause of visual impairment. Historically, treatment of noninfectious uveitis has depended on corticosteroid drugs. Owing to the myriad of side effects caused by corticosteroids, immunomodulatory therapy has become the preferred treatment for chronic noninfectious intraocular inflammation. Recently, biological response modifiers have established a new era in uveitis therapy, with the range of targets continuing to expand. In this review, we aimed to convey up-to-date information on the treatment of noninfectious uveitis to the general ophthalmologist.